Liposarcomas are a common subfamily of soft tissue sarcoma with several subtypes
recognized by the World Health Organization: atypical lipomatous tumors (ALT)/well …

Sarcomas represent a distinct group of rare malignant tumors with high heterogeneity.
Limited options with clinical efficacy for the metastatic or local advanced sarcoma existed …

Oncogenic KIT or PDGFRA receptor tyrosine kinase mutations are compelling therapeutic
targets in gastrointestinal stromal tumor (GIST), and treatment with the KIT/PDGFRA inhibitor …

Background: While soft-tissue sarcomas (STSs) are rare tumors, liposarcomas are among
the most common type of STS and are divided into four main subtypes: atypical lipomatous …

Background Studies have shown that microRNA-191 (miR-191) is involved in the
development and progression of a variety of tumors. However, the function and mechanism …

Sarcomas are a heterogeneous group of malignancies of mesenchymal origin; their
molecular and genomic mechanisms differ with regard to histology. These characteristics …

Rare cancers, which collectively account for almost 25% of all malignancies, are poorly
understood in terms of their aetiology and pathogenesis and are infrequently the focus of …

Simple Summary Soft tissue sarcomas (STSs) are rare malignant conditions with more than
70 subtypes that are difficult to treat, especially in advanced or metastatic states. Recently …

Liposarcoma (LPS) is a common soft tissue sarcoma that encompasses diverse subtypes of
well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic LPS. There is …

The rapidly expanding scenario of treatment options for patients affected by prostate cancer
(PC) is leading to improved outcomes; however, PC still represents one of the most frequent …